Dr Christian Rommel | Global Head of Oncology Discovery
F Hoffman La Roche Ltd

Dr Christian Rommel, Global Head of Oncology Discovery, F Hoffman La Roche Ltd

Christian Rommel has been Roche pRED’s Global Head of Oncology Discovery since 2014. He joined
Roche from Amgen, where he was most recently Vice President of External Research and
Development. Before that role, Christian was Amgen’s Vice President, Research Oncology.
Previously, Christian served as Chief Scientific Officer of Intellikine, a private biotech company based
in San Diego, from its inception to acquisition by Takeda in December 2011. He was responsible for
all discovery and non-clinical activities and led parts of the early clinical development functions.
From 2000 to 2007, Christian was Head of Target Research at Merck-Serono in Geneva, Switzerland.
He also worked as a scientist in the team of George Yancopoulos at Regeneron Pharmaceuticals,
New York.
Christian supported the transition of multiple small or large molecule projects from discovery into
clinical development. He was also involved in several asset in-/out-licensing projects as well as M&A
transactions and/or integration.

Appearances:



EAC 2017 Day 2, Wednesday 1st November 2017 @ 09:05

Keynote Panel: Oncology strategies across pharma

  • High level pharma companies come together to discuss their strategies for tackling cancer
  • Each company will give a 5-minute presentation on their strategy, and a fire side discussion on oncology focused strategies will follow
  • Strategies will cover cytotherapy, checkpoint inhibitors, combination therapy, sequential therapy, approaches to solid tumours, treatments and diagnostics
 

back to speakers